Skip to main content
. 1999 Feb;73(2):1715–1718. doi: 10.1128/jvi.73.2.1715-1718.1999

TABLE 2.

Lytic activity of effector cells on VV-BDV recombinant virus-infected F10 cells

Effector cellsa % Specific lysis of F10 target cells infected with:
BDV VV NLb VV-p24 VV-p40e VV-gp18 VV-gp84/94
Expt Ic
 BDV 80, 66, 25 0, 1, 0 0, 2, 0 6, 0, 0 76, 42, 9 4, 1, 0 5, 0, 0
 VV 3, 2, 0 58, 38, 24 4, 1, 0 62, 33, 12 68, 31, 28 66, 41, 17 57, 37, 21
Expt IIc
 BDV 69, 22, 0 0, 0, 0 3, 1, 0 3, 1, 0 100, 68, 32 0, 1, 0 0, 0, 0
 VV 7, 6, 5 79, 43, 18 5, 9, 0 59, 36, 17 63, 37, 28 56, 31, 17 54, 30, 14
Expt IIId
 BDV 100, 70, 32, 17 0, 2, 1, 0 2, 2, 1, 0 3, 2, 3, 0 81, 60, 25, 8 2, 0, 0, 0 13, 4, 0, 0
 VV 2, 7, 5, 2 52, 34, 13, 3 5, 5, 4, 0 46, 38, 12, 4 53, 44, 16, 7 56, 50, 23, 9 49, 42, 17, 0
a

Effector cells were isolated from the brain of BDV-infected Lewis rats 19 days p.i. and cultivated overnight (BDV), or female Lewis rats were infected i.v. with 107 PFU of VV and spleen cells were taken 6 days p.i. (VV). 

b

NL, noninfected F10 cells. 

c

Results are shown for effector/target cell ratios of 10:1, 3:1, and 1:1, respectively, for BDV and 100:1, 30:1, and 10:1, respectively, for VV. 

d

Results are shown for effector/target cell ratios of 20:1, 7:1, 2:1, and 0.7:1, respectively, for BDV and 100:1, 30:1, 10:1, and 3:1, respectively, for VV. 

e

Boldface values indicate BDV-specific lysis of F10 target cells infected with VV-BDV recombinants.